secwatch / observer
8-K filed February 25, 2022, 6:59 PM ET ticker CLRB CIK 0001279704
leadership confidence high sentiment neutral materiality 0.55

Cellectar Biosciences names Chad Kolean CFO, promotes Jarrod Longcor to COO

Cellectar Biosciences, Inc.

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Jarrod Longcor

Chief Operating Officer
CLRB · Cellectar Biosciences, Inc.
Effective
2022-02-22
Filed
February 25, 2022, 6:59 PM ET
On February 22, 2022, Jarrod Longcor, age 48, was promoted to the Company’s Chief Operating Officer.
Departed

Dov Elefant

Chief Financial Officer
CLRB · Cellectar Biosciences, Inc.
Effective
2022-02-22
Successor
Chad Kolean
Filed
February 25, 2022, 6:59 PM ET
On February 22, 2022, Dov Elefant, the Chief Financial Officer of Cellectar Biosciences, Inc. (the “Company”), resigned from his office effective February 22, 2022.
Appointed

Chad Kolean

Chief Financial Officer
CLRB · Cellectar Biosciences, Inc.
Effective
2022-02-22
Filed
February 25, 2022, 6:59 PM ET
On February 22, 2022, Chad Kolean, age 57, rejoined the Company as its Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jarrod Longcor changed role as Chief Operating Officer at Cellectar Biosciences, Inc..

Action
promoted
Role
Chief Operating Officer
Exact text from the filing
On February 22, 2022, Jarrod Longcor, age 48, was promoted to the Company’s Chief Operating Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dov Elefant resigned as Chief Financial Officer at Cellectar Biosciences, Inc..

Action
resigned
Role
Chief Financial Officer
Exact text from the filing
On February 22, 2022, Dov Elefant, the Chief Financial Officer of Cellectar Biosciences, Inc. (the “Company”), resigned from his office effective February 22, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Chad Kolean was appointed as Chief Financial Officer at Cellectar Biosciences, Inc..

Action
rejoined
Role
Chief Financial Officer
Exact text from the filing
On February 22, 2022, Chad Kolean, age 57, rejoined the Company as its Chief Financial Officer.
View on SEC.gov

Cellectar Biosciences, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-22-027293
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.